Sodium-glucose co-transporter-2 inhibitors (SGLT2i) use and risk of amputation: an expert panel overview of the evidence.
暂无分享,去创建一个
C. Mantzoros | C. Tsioufis | D. Mikhailidis | F. Triposkiadis | G. Dimitriadis | N. Papanas | G. Hahalis | N. Tentolouris | N. Katsiki | V. Tsimihodimos